Table 2: Pre- and post-treatment symptoms and findings scores of the patients.
– |
– |
– |
Min-Max |
Median |
Mean±sd |
Age |
– |
– |
5,0 - 55,0 |
14,0 |
18,0± 11,4 |
Sex |
– |
Female |
– |
– |
46 |
57,5% |
Male |
34 |
42,5% |
Itching |
Before |
Mild |
– |
– |
7 |
8,8% |
Medication |
Moderate |
51 |
63,8% |
– |
Severe |
22 |
27,5% |
After Medication |
None |
– |
– |
46 |
57,5% |
Mild |
34 |
42,5% |
Tearing |
Before |
Mild |
– |
– |
25 |
31,3% |
Medication |
Moderate |
40 |
50,0% |
– |
Severe |
15 |
18,8% |
After Medication |
None |
– |
– |
54 |
67,5% |
Mild |
25 |
31,3% |
Moderate |
1 |
1,3% |
Discomfort |
Before |
Mild |
– |
– |
35 |
43,8% |
Medication |
Moderate |
39 |
48,8% |
– |
Severe |
6 |
7,5% |
After Medication |
None |
– |
– |
54 |
67,5% |
Mild |
26 |
32,5% |
Photophobia |
Before |
Mild |
– |
– |
34 |
42,5% |
Medication |
Moderate |
42 |
52,5% |
– |
Severe |
4 |
5,0% |
After Medication |
None |
– |
– |
65 |
81,3% |
Mild |
15 |
18,8% |
Hyperemia |
Before |
Mild |
– |
– |
18 |
22,5% |
Medication |
Moderate |
49 |
61,3% |
– |
Severe |
13 |
16,3% |
After Medication |
None |
– |
– |
74 |
92,5% |
Mild |
6 |
7,5% |
Papillae |
Before |
Mild |
– |
– |
13 |
16,3% |
Medication |
Moderate |
52 |
65,0% |
– |
Severe |
15 |
18,8% |
After Medication |
None |
– |
– |
55 |
68,8% |
Mild |
22 |
27,5% |
Moderate |
3 |
3,8% |
Chemosis |
Before |
None |
– |
– |
67 |
83,8% |
Medication |
Mild |
13 |
16,3% |
After Medication |
None |
– |
– |
76 |
95,0% |
Mild |
4 |
5,0% |
Lid Edema |
Before |
None |
– |
– |
71 |
88,8% |
Medication |
Mild |
9 |
11,3% |
After Medication |
None |
– |
– |
79 |
98,8% |
Mild |
1 |
1,3% |